Involvement of CD44 in mast cell proliferation during terminal differentiation

Laboratory Investigation

Volumn 89, Issue 4, 2009, Pages 446-455

  Takano, Hirotsugu ^a   Nakazawa, Shunsuke ^a   Shirata, Naritoshi ^a   Tamba, Shigero ^a   Furuta, Kazuyuki ^a   Tsuchiya, Sohken ^a   Morimoto, Kazushi ^a   Itano, Naoki ^b   Irie, Atsushi ^c   Ichikawa, Atsushi ^d   Kimata, Koji ^e   Nakayama, Kazuhisa ^a   Sugimoto, Yukihiko ^a   Tanaka, Satoshi ^d  

^a KYOTO UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

^e AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

CD44; Fibroblast; Hyaluronan; Mast cell; Proliferation

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; TOLONIUM CHLORIDE;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL COUNT; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; EAR; FEMALE; FIBROBLAST; MALE; MAST CELL; MOUSE; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; SKIN CELL; TRANSCRIPTION INITIATION;

EID: 63449101087     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2008.159     Document Type: Article

References (30)

1. Metz M, Grimbaldeston MA, Nakae S, et al. Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 2007;217: 304-328.
2. Metz M, Maurer M. Mast cells-key effector cells in immune responses. Trends Immunol 2007;28:234-241.
3. Kitamura Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu Rev Immunol 1989;7:59-76.
4. Takano H, Nakazawa S, Okuno Y, et al. Establishment of the culture model system that reflects the process of terminal differentiation of connective tissue-type mast cells. FEBS Lett 2008;582:1444-1450.
5. Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 2004;4:33-45.
6. Puré E, Cuff CA. A crucial role for CD44 in inflammation. Trends Mol Med 2001;7:213-221.
7. Tammi M, Day AJ, Turley EA. Hyaluronan and homeostasis: a balancing act. J Biol Chem 2002;277:4581-4584.
8. Laurent TC, Fraser JR. Hyaluronan. FASEB J 1992;6:2397-2404.
9. McLachlan JB, Hart JP, Pizzo SV, et al. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat Immunol 2003;4:1199-1205.
10. Jawdat DM, Rowden G, Marshall JS. Mast cells have a pivotal role in TNF-independent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan. J Immunol 2006;177:1755-1762.
11. Lu LF, Lind EF, Bennett DC, et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006;442:997-1002.
12. Protin U, Schweighoffer T, Jochum W, et al. CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocytes subsets. J Immunol 1999;163:4917-4923.
13. Tanaka S, Takasu Y, Mikura S, et al. Antigen-independent induction of histamine synthesis by immunoglobulin E in mouse bone marrowderived mast cells. J Exp Med 2002;196:229-235.
14. He D, Esquenazi-Behar S, Soter NA, et al. Mast-cell heterogeneity: functional comparison of purified mouse cutaneous and peritoneal mast cells. J Invest Dermatol 1990;95:178-185.
15. 2+ influx-mediated histamine synthesis and IL-6 release in mast cells activated by monomeric IgE. Eur J Immunol 2005;35:460-468.
16. Kitchen JR, Cysyk RL. Synthesis and release of hyaluronic acid by Swiss 3T3 fibroblasts. Biochem J 1995;309:649-655.
17. Bergstresser PR, Tigelaar RE, Tharp MD. Conjugated avidin identifies cutaneous rodent and human mast cells. J Invest Dermatol 1984;83:214-218.
18. Zheng Z, Katoh S, He Q, et al. Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J Cell Biol 1995;130: 485-495.
19. Chen C, Grimbaldeston MA, Tsai M, et al. Identification of mast cell progenitors in adult mice. Proc Natl Acad Sci USA 2005;102: 11408-11413.
20. Arinobu Y, Iwasaki H, Gurish MF, et al. Development checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis. Proc Natl Acad Sci USA 2005;102:18105-18110.
21. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997;77:1033-1079.
22. Lee DM, Friend DS, Gurish MF, et al. Mast cell: a cellular link between autoantibodies and inflammatory arthritis. Science 2002;297: 1689-1692.
23. Maruotti N, Crivellato E, Cantatore FP, et al. Mast cells in rheumatoid arthritis. Clin Rheumatol 2007;26:1-4.
24. Naor D, Nedvetzki S. CD44 in rheumatoid arthritis. Arthritis Res Ther 2003;5:105-115.
25. Fukui M, Whittlesey K, Metcalfe DD, et al. Human mast cells express the hyaluronic-acid-binding isoform of CD44 and adhere to hyaluronic acid. Clin Immunol 2000;94:173-178.
26. Sherman LS, Rizvi TA, Karyala S, et al. CD44 enhances neuregulin signaling by Schwann cells. J Cell Biol 2000;150:1071-1084.
27. Singleton PA, Salgia R, Moreno-Vinasco L, et al. CD44 regulates hepatocyte growth factor-mediated vascular integrity. J Bio Chem 2007;282:30643-30657.
28. Ghatak S, Misra S, Toole BP. Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells. J Biol Chem 2005;280:8875-8883.
29. Tolg C, Hamilton SR, Nakrieko KA, et al. Rhamm-/- fibroblasts are defective in CD44-mediated ERK1, 2 motogenic signaling, leading to defective skin wound repair. J Cell Biol 2006;175:1017-1028.
30. Nedvetzki S, Gonen E, Assayag N, et al. RHAMM, receptor for hyaluronan-mediated motility, compensate for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy. Proc Natl Acad Sci USA 2004;101:18081-18086.